Stay updated on AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial

Sign up to get notified when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Version 6 adds core study record sections—Study Design, Study Description, Sponsor/Collaborators, Study Status, and Study Identification (revision: v3.4.2). It also removes the previous government funding notice and the AnHeart Therapeutics reference.
    Difference
    3%
    Check dated 2026-02-11T02:54:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding was added and the site version updated from v3.4.0 to v3.4.1; the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T01:26:19.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page now shows a 'Show glossary' option and legends for green additions and red deletions, and the revision version was updated to v3.4.0 with a No FEAR Act Data entry.
    Difference
    1%
    Check dated 2026-01-27T22:38:08.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 appears in the record history with provenance details (AnHeart Therapeutics Inc., 2023-10, verified, unknown status), replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-13T17:56:56.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The record history shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure and an older revision entry (v3.3.2), which are minor metadata updates to the site. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T09:42:01.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 has been added to the Study Record Versions, replacing the previous v3.2.0 entry.
    Difference
    0.1%
    Check dated 2025-11-24T17:35:43.000Z thumbnail image

Stay in the know with updates to AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.